Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Arcadia Biosciences (RKDA) over the last 12 years, with Q3 2025 value amounting to $16525.0.

  • Arcadia Biosciences' Other Working Capital Changes rose 3140.11% to $16525.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $16525.0, marking a year-over-year increase of 3140.11%. This contributed to the annual value of $21406.0 for FY2024, which is 701162.79% up from last year.
  • Per Arcadia Biosciences' latest filing, its Other Working Capital Changes stood at $16525.0 for Q3 2025, which was up 3140.11% from $16525.0 recorded in Q2 2025.
  • In the past 5 years, Arcadia Biosciences' Other Working Capital Changes registered a high of $928000.0 during Q4 2021, and its lowest value of -$208000.0 during Q1 2022.
  • Its 5-year average for Other Working Capital Changes is $149164.4, with a median of $16525.0 in 2025.
  • In the last 5 years, Arcadia Biosciences' Other Working Capital Changes soared by 588857.14% in 2024 and then crashed by 1157174.03% in 2025.
  • Arcadia Biosciences' Other Working Capital Changes (Quarter) stood at $928000.0 in 2021, then tumbled by 32.44% to $627000.0 in 2022, then decreased by 8.77% to $572000.0 in 2023, then soared by 40.21% to $802000.0 in 2024, then crashed by 97.94% to $16525.0 in 2025.
  • Its last three reported values are $16525.0 in Q3 2025, $16525.0 for Q2 2025, and -$205000.0 during Q1 2025.